Ileal Bile Acid Transporter Inhibitor [EPC]

455 reported adverse events

Drugs of this class: LINERIXIBAT ODEVIXIBAT

These side effects are most commonly reported by patients taking drugs of the Ileal Bile Acid Transporter Inhibitor [EPC] class:

# Side effect Count
0 DIARRHOEA 113
1 PRURITUS 109
2 OFF LABEL USE 104
3 DRUG INEFFECTIVE 48
4 LIVER TRANSPLANT 36
5 ABDOMINAL PAIN UPPER 31
6 PRODUCT DOSE OMISSION ISSUE 30
7 HEPATIC ENZYME INCREASED 25
8 ABDOMINAL PAIN 23
9 BLOOD BILIRUBIN INCREASED 22
See all common reactions for Ileal Bile Acid Transporter Inhibitor [EPC]

Drugs of the Ileal Bile Acid Transporter Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 2 0.1429
1 BILE ACIDS INCREASED 20 0.1130
2 EXTRA-AXIAL HAEMORRHAGE 1 0.0588
3 BILE ACIDS ABNORMAL 1 0.0455
4 POOR SCHOOL ATTENDANCE 1 0.0400
5 ADENOVIRAL UPPER RESPIRATORY INFECTION 1 0.0345
6 CHOLESTATIC PRURITUS 1 0.0312
7 MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED 1 0.0256
8 GASTROENTERITIS ASTROVIRAL 2 0.0250
9 STAPHYLOCOCCAL IMPETIGO 1 0.0175
See all enriched reactions for Ileal Bile Acid Transporter Inhibitor [EPC]